Oily Skin: What Could Be Causing It and How to Treat It

What Oily Skin Actually Is: The Sebaceous Gland Basics

Oily skin, clinically called seborrhea, occurs when sebaceous glands secrete more sebum than the skin surface needs. Sebum is a lipid-rich mixture of triglycerides, wax esters, squalene, and free fatty acids. At normal output levels it protects the skin barrier. Above a certain threshold it creates the visible shine, enlarged pores, and comedone formation most people recognize as "oily skin." Skin barrier physiology is reviewed in detail by Proksch et al. At PubMed.

How Sebaceous Glands Work

Sebaceous glands are holocrine structures attached to hair follicles across most of the body. The face, scalp, chest, and upper back carry the highest gland density, roughly 400 to 900 glands per square centimeter on the nose alone. Sebocytes (the gland's secretory cells) accumulate lipids, rupture, and release their contents into the follicular canal. The entire cycle from cell birth to secretion takes about two to three weeks.

Androgen receptors sit on sebocyte membranes. When dihydrotestosterone (DHT) binds these receptors, sebocyte proliferation accelerates and lipid synthesis increases. This is why puberty, the event that triggers the adrenal and gonadal androgen surge, is also the period when oily skin first appears in most people. Thiboutot et al. Published a detailed review of sebaceous gland regulation in the Journal of Investigative Dermatology.

The Sebum Excretion Rate

Researchers measure sebum output using a sebumeter or Sebutape. Normal adult sebum excretion rates range from about 1 to 2 micrograms per square centimeter per minute on the forehead. Values above 3 micrograms per square centimeter per minute consistently correlate with patient-reported "oily" skin. This number is not fixed. It fluctuates with age, hormone levels, ambient temperature, and relative humidity.

Hormonal Causes of Oily Skin

Androgens are the single biggest driver of excess sebum. Several conditions push androgen levels high enough to produce noticeable oiliness, and distinguishing among them requires specific lab work.

Puberty and Physiologic Androgen Surges

Testosterone and its more potent derivative DHT rise sharply during puberty, peaking in the mid-teens for girls and the late teens for boys. Sebaceous gland size and output track these changes almost one-to-one. For most adolescents this is entirely physiologic, meaning no underlying pathology exists. Sebum output tends to decline gradually after age 20 in women and after age 35 in men, which is why adults often report less oiliness as they age. A longitudinal study by Jacobsen et al. In the British Journal of Dermatology documented sebum excretion rate changes across the lifespan.

Polycystic Ovary Syndrome (PCOS)

PCOS affects an estimated 6 to 12 percent of reproductive-age women in the United States, according to CDC data. CDC PCOS fact sheet available here. Excess androgen production, either ovarian or adrenal in origin, drives the oily skin and acne that are among the most common presenting complaints. The Rotterdam criteria require two of three features: oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound.

Women with PCOS frequently report that their skin becomes dramatically oilier in the luteal phase or when they are anovulatory for multiple consecutive cycles. Lab findings typically show elevated free testosterone, elevated DHEA-S in adrenal-predominant cases, and an LH-to-FSH ratio above 2:1. The Endocrine Society's 2023 clinical practice guideline on PCOS is accessible at endocrine.org.

Congenital Adrenal Hyperplasia (CAH)

Non-classic CAH, caused by a partial deficiency of 21-hydroxylase, can present in adolescence or early adulthood with oily skin, acne, and hirsutism that mimic PCOS. Serum 17-hydroxyprogesterone drawn in the early morning follicular phase is the screening test. Values above 200 ng/dL warrant an ACTH stimulation test to confirm the diagnosis. A clinical review in the Journal of Clinical Endocrinology and Metabolism covers CAH presentation in detail.

Androgen-Secreting Tumors

Rapid-onset virilization, a deepening voice, clitoromegaly, and total testosterone above 150 to 200 ng/dL should prompt imaging of the adrenal glands and ovaries to exclude an androgen-secreting tumor. This presentation is rare but warrants urgent evaluation.

Testosterone Replacement Therapy (TRT) and Anabolic Steroids

Exogenous androgens predictably increase sebum output. Men on testosterone replacement therapy frequently report oily skin within the first four to eight weeks of starting treatment, particularly at the injection site area. Anabolic-androgenic steroids used illicitly carry the same effect, often more pronounced. Dose reduction or switching to a 5-alpha reductase inhibitor (finasteride 1 mg daily) may reduce sebum output in TRT patients. FDA prescribing information for testosterone products is available at accessdata.fda.gov.

Genetic Factors

Heritability of sebum production is substantial. Twin studies estimate that genetic factors account for roughly 60 percent of variance in sebum excretion rate. Specific polymorphisms in the androgen receptor gene (AR) and in genes encoding 5-alpha reductase type 1 (SRD5A1) have been associated with higher sebum output in genome-wide association data. A relevant genetic analysis was published by Bataille et al. In the Journal of Investigative Dermatology.

If both biological parents have oily skin, an individual has a meaningfully higher probability of the same trait compared with someone whose parents have dry skin. This baseline genetic predisposition explains why two people with identical hormone levels can have very different skin types.

Environmental and Lifestyle Causes

Humidity and Heat

Sebaceous gland activity responds to ambient temperature. A study published in the British Journal of Dermatology found that sebum excretion rate rose significantly in subjects moved from a temperate to a tropical environment over four weeks. Hot, humid climates accelerate lipid secretion and slow the evaporation of sebum from the skin surface, compounding the oily appearance.

Diet

The relationship between diet and sebum is actively researched. High-glycemic-index diets appear to promote sebum production by increasing insulin and insulin-like growth factor 1 (IGF-1) levels, both of which stimulate androgen synthesis in the skin. A randomized controlled trial by Smith et al. Published in the American Journal of Clinical Nutrition (N=43) found that a low-glycemic-load diet reduced total lesion counts and led to measurable decreases in sebum output compared with a high-glycemic control diet over 12 weeks. Smith RN et al. In the American Journal of Clinical Nutrition.

Dairy consumption, particularly skim milk, has been associated with acne and possibly higher sebum output, though the evidence is less consistent than for glycemic load.

Over-Washing and Barrier Disruption

Washing the face more than twice daily with harsh cleansers strips the stratum corneum of its lipid layer. The skin may respond by increasing sebum secretion to compensate, a phenomenon sometimes called "rebound oiliness." Gentle, pH-balanced cleansers used twice daily minimize this effect.

Certain Medications

Several drug classes increase sebum output as a side effect. Lithium, corticosteroids, certain progestins with androgenic activity (levonorgestrel, norgestrel), and cyclosporine have all been associated with seborrhea or acneiform eruptions. Patients starting these medications should be counseled that oily skin is a possible side effect rather than a separate condition requiring independent workup.

Skin Conditions That Feature or Mimic Oily Skin

Seborrheic Dermatitis

Seborrheic dermatitis is a chronic inflammatory condition of sebum-rich skin areas. The face (nasolabial folds, eyebrows, scalp margins), scalp, and chest are most affected. Malassezia yeast species colonize sebum-rich skin and trigger an inflammatory response in susceptible individuals. Patients describe scaling, redness, and itching on top of the oily baseline. Treatment targets both the yeast load (ketoconazole 2% shampoo or cream) and the inflammation (low-potency topical corticosteroids). A Cochrane review of interventions for seborrheic dermatitis is available at the Cochrane Library.

Acne Vulgaris

Acne and oily skin are tightly linked. The pathophysiology involves four steps: excess sebum, follicular hyperkeratinization, Cutibacterium acnes (formerly Propionibacterium acnes) colonization, and inflammation. The AAD estimates that acne affects up to 50 million Americans annually. Treating the underlying seborrhea is central to acne management, not just an adjunct to it.

Rosacea (Oily Subtype)

A subset of rosacea patients, particularly those with papulopustular or phymatous subtypes, report oily skin. The mechanism differs from androgenic seborrhea and may involve altered innate immune responses. Misidentifying rosacea as simple oily skin leads to inappropriate use of irritating topical products that worsen redness and vascular reactivity.

How Oily Skin Is Diagnosed

Diagnosis is primarily clinical. A dermatologist or primary care physician inspects the skin under good lighting, assessing sebum distribution, pore size, and the presence of comedones, papules, or scaling. The question of whether to pursue lab work depends on the clinical picture.

When Lab Work Is Indicated

Lab evaluation is appropriate when oily skin accompanies any of the following: irregular menstrual cycles, hirsutism, male-pattern hair loss in women, rapid-onset virilization, or failure to respond to standard topical therapy after 12 weeks. A reasonable first panel includes:

• Total and free testosterone
• DHEA-S (dehydroepiandrosterone sulfate)
• 17-hydroxyprogesterone (early morning, follicular phase)
• LH and FSH
• Fasting insulin and glucose (if PCOS is suspected)
• Prolactin (to exclude hyperprolactinemia)

Sebumeter Measurement

In research settings and some specialty dermatology practices, a sebumeter provides an objective sebum excretion rate. This is not standard in most clinical encounters but can be useful for tracking treatment response in clinical trials or for patients who want quantitative data.

The HealthRX clinical team uses the following decision framework for patients presenting with oily skin:

Step 1. Establish whether oiliness is isolated or accompanied by systemic signs (hirsutism, cycle irregularity, rapid weight gain, voice changes). Isolated oily skin with no systemic features rarely needs blood work beyond a clinical exam.

Step 2. If systemic signs are absent, treat empirically with topical retinoid plus a gentle cleanser for 12 weeks. Document response.

Step 3. If systemic signs are present or topical therapy fails at 12 weeks, order the lab panel above. Route results to a physician for interpretation.

Step 4. Match systemic treatment to the identified cause: spironolactone for androgen excess in women, combined oral contraceptive with anti-androgenic progestin (drospirenone or cyproterone acetate), or isotretinoin for severe refractory seborrhea regardless of androgen status.

Treatment Options for Oily Skin

Treatment efficacy depends on correctly identifying the cause. Generic "oil control" products marketed at consumers address surface sebum but do not alter gland output. Evidence-based options go deeper.

Topical Retinoids

Retinoids bind retinoic acid receptors in sebocytes and reduce sebum production while normalizing follicular keratinization. Adapalene 0.1% gel, available over the counter since 2016, is a reasonable starting point. Tretinoin 0.025 to 0.05% is prescription-only and slightly more potent for sebum reduction. Patients should apply a pea-sized amount to dry skin every other night for the first two weeks, then nightly, to minimize irritation. The AAD acne guideline recommends topical retinoids as first-line therapy for comedonal and mild inflammatory acne, a condition inseparable from excess sebum.

Topical Niacinamide

Niacinamide (vitamin B3) at 2 to 5% concentration reduces sebum excretion rate in small controlled studies and is well tolerated. A split-face study published in the International Journal of Dermatology (N=20) found that 2% niacinamide lotion applied twice daily for four weeks reduced sebum output by approximately 30% compared with vehicle. Vergou T et al., International Journal of Dermatology.

Spironolactone

Spironolactone is a potassium-sparing diuretic that also blocks androgen receptors at doses of 25 to 200 mg daily. Used off-label for oily skin and acne in women, it is not approved for men due to feminizing side effects. A retrospective cohort analysis published in the Journal of the American Academy of Dermatology (N=400) found that 85% of women reported improved acne and oiliness at doses of 100 to 150 mg daily. Charny JW et al., Journal of the American Academy of Dermatology.

Potassium monitoring is recommended at baseline and at three months, particularly in women with renal impairment or those taking ACE inhibitors.

Oral Isotretinoin

Isotretinoin is the only agent that produces sustained reduction in sebaceous gland size. A standard course of 0.5 to 1.0 mg/kg/day for five to six months reduces sebaceous gland size by up to 90% and sebum output by 70 to 80%. Remission after one course lasts years in many patients. The drug carries a category X pregnancy risk and requires enrollment in the iPLEDGE program in the United States. FDA iPLEDGE program information.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) with anti-androgenic progestins reduce free testosterone by increasing sex hormone-binding globulin (SHBG). Formulations containing drospirenone or cyproterone acetate show the strongest sebum-lowering effect in clinical trials. The FDA has approved three COCs specifically for acne (Ortho Tri-Cyclen, Estrostep Fe, and Beyaz), all of which reduce oiliness as part of their mechanism. FDA-approved labeling for drospirenone-containing COCs at accessdata.fda.gov.

Procedural Options

Chemical peels using glycolic acid (20 to 70%) or salicylic acid (20 to 30%) reduce follicular plugging and transiently decrease sebum output. Photodynamic therapy with aminolevulinic acid targets and partially destroys sebaceous glands; studies show sebum reduction of 40 to 75% lasting six to twelve months. These are typically reserved for patients who cannot tolerate or are contraindicated for systemic therapy.

When to Worry About Oily Skin

Isolated oily skin without systemic features is almost never dangerous. Concern rises with the following signs:

• Total serum testosterone above 150 to 200 ng/dL in a woman
• Sudden onset of oily skin over weeks rather than gradual onset over months
• Clitoromegaly, deepening voice, or breast atrophy
• Oily skin onset after age 35 in someone without a prior history
• Failure of standard therapy after 16 weeks

Any of these findings warrant endocrinology or gynecology referral for androgen-secreting tumor workup.

The Endocrine Society states in its hyperandrogenism guideline that "total testosterone concentrations greater than 150 ng/dL in women are associated with an increased likelihood of an androgen-secreting neoplasm and require imaging of the adrenal glands and ovaries." Endocrine Society Clinical Practice Guideline on Androgen Excess.